Functional diversity increases the efficacy of phage combinations (2021)

First Author: Wright R

Attributed to: Does CRISPR-Cas immunity limit the effectiveness of phage therapy? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.07.09.451746

Publication URI: http://dx.doi.org/10.1101/2021.07.09.451746

Type: Preprint